Free Trial
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

$1.85
+0.06 (+3.08%)
(As of 11:49 AM ET)
Today's Range
$1.80
$1.97
50-Day Range
$1.37
$1.97
52-Week Range
$1.25
$14.40
Volume
38,741 shs
Average Volume
80,097 shs
Market Capitalization
$3.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BKYI stock logo

About BIO-key International Stock (NASDAQ:BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BKYI Stock Price History

BKYI Stock News Headlines

New Biden Law just went into effect
Congress has allocated $400 billion to support this law, and is considering approving billions more by the end of this year. And leaders from both sides of the aisle just issued a joint statement calling the signing of this law “a momentous day” for America – and critical to national security.
BIO-key International Inc BKYI
New Biden Law just went into effect
Congress has allocated $400 billion to support this law, and is considering approving billions more by the end of this year. And leaders from both sides of the aisle just issued a joint statement calling the signing of this law “a momentous day” for America – and critical to national security.
BIO-key faces Nasdaq non-compliance notice
BIO-key International Inc
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/14/2024
Today
7/15/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BKYI
Employees
51
Year Founded
N/A

Profitability

Net Income
$-8,520,000.00
Pretax Margin
-96.33%

Debt

Sales & Book Value

Annual Sales
$7.76 million
Book Value
$1.03 per share

Miscellaneous

Free Float
1,565,000
Market Cap
$3.25 million
Optionable
Optionable
Beta
0.38
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed this year?

BIO-key International's stock was trading at $3.00 at the beginning of the year. Since then, BKYI stock has decreased by 39.3% and is now trading at $1.82.
View the best growth stocks for 2024 here
.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) released its quarterly earnings data on Friday, June, 14th. The technology company reported ($0.32) earnings per share for the quarter. The technology company had revenue of $2.18 million for the quarter. BIO-key International had a negative net margin of 96.03% and a negative trailing twelve-month return on equity of 340.45%.

When did BIO-key International's stock split?

BIO-key International shares reverse split on Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX) and Heat Biologics (HTBX).

This page (NASDAQ:BKYI) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners